PT868184E - Microgranulos de libertacao prolongada contendo diltiazem como principio activo - Google Patents

Microgranulos de libertacao prolongada contendo diltiazem como principio activo

Info

Publication number: PT868184E
Authority: PT; Portugal
Prior art keywords: microgranules; active ingredient; containing diltiazem; prolonged liberation; liberation
Prior art date: 1995-12-22

Application number

PT96943156T

Other languages

English (en)

Inventor

Patrice Debregeas

Gerard Leduc

Pascal Oury

Pascal Suplie

Original Assignee

Ethypharm Lab Prod Ethiques

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-22

Filing date

1996-12-23

Publication date

2003-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9485856&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT868184(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-12-23 Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques

2003-09-30 Publication of PT868184E publication Critical patent/PT868184E/pt

Links

239000004480 active ingredient Substances 0.000 title 1
HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 title 1
229960004166 diltiazem Drugs 0.000 title 1
230000002035 prolonged effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

PT96943156T 1995-12-22 1996-12-23 Microgranulos de libertacao prolongada contendo diltiazem como principio activo PT868184E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9515361A FR2742660B1 (fr)	1995-12-22	1995-12-22	Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

Publications (1)

Publication Number	Publication Date
PT868184E true PT868184E (pt)	2003-09-30

Family

ID=9485856

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT96943156T PT868184E (pt)	1995-12-22	1996-12-23	Microgranulos de libertacao prolongada contendo diltiazem como principio activo

Country Status (26)

Country	Link
US (3)	US6228395B1 (pt)
EP (1)	EP0868184B1 (pt)
JP (1)	JP2000506500A (pt)
KR (1)	KR100354054B1 (pt)
CN (1)	CN1145488C (pt)
AR (1)	AR004410A1 (pt)
AT (1)	ATE238798T1 (pt)
AU (1)	AU721949B2 (pt)
BG (1)	BG63770B1 (pt)
BR (1)	BR9612225A (pt)
CA (1)	CA2242224C (pt)
DE (1)	DE69627880T2 (pt)
DK (1)	DK0868184T3 (pt)
EA (1)	EA001721B1 (pt)
EE (1)	EE04045B1 (pt)
ES (1)	ES2198505T3 (pt)
FR (1)	FR2742660B1 (pt)
GE (1)	GEP20022629B (pt)
HU (1)	HU224214B1 (pt)
IL (1)	IL125047A (pt)
NO (1)	NO324680B1 (pt)
NZ (1)	NZ324739A (pt)
PL (1)	PL186621B1 (pt)
PT (1)	PT868184E (pt)
WO (1)	WO1997023219A1 (pt)
ZA (1)	ZA9610776B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2742660B1 (fr) *	1995-12-22	1998-04-03	Ethypharm Lab Prod Ethiques	Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US6162463A (en) *	1997-05-01	2000-12-19	Dov Pharmaceutical Inc	Extended release formulation of diltiazem hydrochloride
FR2790668B1 (fr) *	1999-03-12	2002-07-26	D B F	Granules contenant une substance vegetale et leur procede de preparation
EP1064937A1 (en) *	1999-06-28	2001-01-03	Sanofi-Synthelabo	Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
EP1064938A1 (en) *	1999-06-28	2001-01-03	Sanofi-Synthelabo	Pharmaceutical dosage forms for controlled release producing at least a timed pulse
US7108866B1 (en)	1999-12-10	2006-09-19	Biovall Laboratories International Srl	Chronotherapeutic diltiazem formulations and the administration thereof
US7179483B2 (en)	2000-04-26	2007-02-20	Watson Pharmaceuticals, Inc.	Compositions and methods for transdermal oxybutynin therapy
FR2831546B1 (fr) *	2001-10-31	2007-03-23	Atofina	Materiau polymere thermoplastique pour supports d'enregistrement d'informations audio et/ou optiques
KR101148734B1 (ko) *	2003-10-10	2012-07-05	에띠빠흠	징코 빌로바 추출물을 포함하는 서방형 미세과립 및 이것을 제조하는 방법
JPWO2005065715A1 (ja) *	2003-12-25	2007-07-26	武田薬品工業株式会社	造粒性改善方法
JP2005306778A (ja) *	2004-04-21	2005-11-04	Basf Ag	徐放性製剤及びその製造方法
WO2006013431A1 (en) *	2004-07-29	2006-02-09	Pfizer Limited	Stable controlled-release pharmaceutical formulation of eletriptan
US8778395B2 (en) *	2005-08-11	2014-07-15	Andrx Labs, Llc	Diltiazem controlled release formulation and method of manufacture
SI2719378T1 (sl) *	2006-06-19	2016-11-30	Alpharma Pharmaceuticals Llc	Farmacevtski sestavki
ITFI20110172A1 (it)	2011-08-08	2013-02-09	Valpharma Sa	Formulazione multiparticolata a rilascio modificato di diltiazem hcl.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE56999B1 (en) *	1983-12-22	1992-03-11	Elan Corp Plc	Pharmaceutical formulation
IT1200217B (it) *	1986-09-30	1989-01-05	Valducci Roberto	Membrana per uso farmaceutico ed industriale
DK173505B1 (da) *	1987-02-20	2001-01-15	Pharmatec Internat S R L	Fremgangsmåde til fremstilling af en diltiazempellet med langsom afgivelse og anvendelse af således fremstillede pelleter t
JPH07552B2 (ja) *	1987-11-06	1995-01-11	田辺製薬株式会社	持効性製剤
FR2623714B1 (fr) *	1987-11-26	1990-04-20	Ethypharm Sa	Forme a liberation prolongee du diltiazem, et son medicament ainsi obtenu
FR2624732B1 (fr) *	1987-12-21	1991-02-15	Synthelabo	Formulation pharmaceutique a liberation prolongee
FR2630647B1 (fr) *	1988-04-27	1991-08-16	Sanofi Sa	Microbilles de diltiazem, leur procede de fabrication et compositions pharmaceutiques a liberation prolongee les contenant
US5288505A (en)	1991-06-26	1994-02-22	Galephar P.R., Inc., Ltd.	Extended release form of diltiazem
US5229135A (en) *	1991-11-22	1993-07-20	Prographarm Laboratories	Sustained release diltiazem formulation
US5376384A (en)	1992-12-23	1994-12-27	Kinaform Technology, Inc.	Delayed, sustained-release pharmaceutical preparation
US5834024A (en) *	1995-01-05	1998-11-10	Fh Faulding & Co. Limited	Controlled absorption diltiazem pharmaceutical formulation
FR2742660B1 (fr) *	1995-12-22	1998-04-03	Ethypharm Lab Prod Ethiques	Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif

1995
- 1995-12-22 FR FR9515361A patent/FR2742660B1/fr not_active Expired - Lifetime
1996
- 1996-12-20 ZA ZA9610776A patent/ZA9610776B/xx unknown
- 1996-12-23 HU HU9904129A patent/HU224214B1/hu active IP Right Grant
- 1996-12-23 EP EP96943156A patent/EP0868184B1/fr not_active Expired - Lifetime
- 1996-12-23 ES ES96943156T patent/ES2198505T3/es not_active Expired - Lifetime
- 1996-12-23 WO PCT/FR1996/002040 patent/WO1997023219A1/fr not_active Ceased
- 1996-12-23 GE GEAP19964360A patent/GEP20022629B/en unknown
- 1996-12-23 US US09/091,646 patent/US6228395B1/en not_active Expired - Fee Related
- 1996-12-23 CN CNB961997648A patent/CN1145488C/zh not_active Expired - Lifetime
- 1996-12-23 EA EA199800593A patent/EA001721B1/ru not_active IP Right Cessation
- 1996-12-23 DK DK96943156T patent/DK0868184T3/da active
- 1996-12-23 NZ NZ324739A patent/NZ324739A/xx not_active IP Right Cessation
- 1996-12-23 BR BR9612225A patent/BR9612225A/pt not_active IP Right Cessation
- 1996-12-23 IL IL12504796A patent/IL125047A/xx not_active IP Right Cessation
- 1996-12-23 AR ARP960105884A patent/AR004410A1/es unknown
- 1996-12-23 JP JP9523365A patent/JP2000506500A/ja active Pending
- 1996-12-23 CA CA002242224A patent/CA2242224C/fr not_active Expired - Lifetime
- 1996-12-23 PT PT96943156T patent/PT868184E/pt unknown
- 1996-12-23 EE EE9800197A patent/EE04045B1/xx unknown
- 1996-12-23 AT AT96943156T patent/ATE238798T1/de active
- 1996-12-23 AU AU11983/97A patent/AU721949B2/en not_active Expired
- 1996-12-23 DE DE69627880T patent/DE69627880T2/de not_active Expired - Lifetime
- 1996-12-23 PL PL96327567A patent/PL186621B1/pl unknown
- 1996-12-23 KR KR10-1998-0704833A patent/KR100354054B1/ko not_active Expired - Fee Related
1998
- 1998-06-12 NO NO19982738A patent/NO324680B1/no not_active IP Right Cessation
- 1998-06-18 BG BG102555A patent/BG63770B1/bg unknown
2001
- 2001-01-11 US US09/757,628 patent/US6383516B1/en not_active Expired - Lifetime
- 2001-12-03 US US09/998,911 patent/US6660296B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
KR19990076717A (ko)	1999-10-15
ES2198505T3 (es)	2004-02-01
HK1018400A1 (en)	1999-12-24
EE04045B1 (et)	2003-06-16
US20020182253A1 (en)	2002-12-05
KR100354054B1 (ko)	2003-02-14
HU224214B1 (hu)	2005-06-28
GEP20022629B (en)	2002-02-25
CN1145488C (zh)	2004-04-14
EP0868184A1 (fr)	1998-10-07
AU1198397A (en)	1997-07-17
EA001721B1 (ru)	2001-08-27
US6383516B1 (en)	2002-05-07
NO982738L (no)	1998-08-21
ATE238798T1 (de)	2003-05-15
IL125047A (en)	2003-05-29
CA2242224C (fr)	2004-01-13
CA2242224A1 (fr)	1997-07-03
ZA9610776B (en)	1997-06-30
DK0868184T3 (da)	2003-08-25
BG63770B1 (bg)	2002-12-29
FR2742660A1 (fr)	1997-06-27
HUP9904129A2 (hu)	2000-04-28
FR2742660B1 (fr)	1998-04-03
PL186621B1 (pl)	2004-02-27
EA199800593A1 (ru)	1998-12-24
PL327567A1 (en)	1998-12-21
BG102555A (en)	1999-02-26
BR9612225A (pt)	1999-07-13
DE69627880D1 (de)	2003-06-05
JP2000506500A (ja)	2000-05-30
EE9800197A (et)	1998-12-15
US6228395B1 (en)	2001-05-08
CN1207681A (zh)	1999-02-10
IL125047A0 (en)	1999-01-26
AU721949B2 (en)	2000-07-20
EP0868184B1 (fr)	2003-05-02
HUP9904129A3 (en)	2000-11-28
NO324680B1 (no)	2007-12-03
NZ324739A (en)	2000-01-28
AR004410A1 (es)	1998-11-04
WO1997023219A1 (fr)	1997-07-03
US6660296B2 (en)	2003-12-09
NO982738D0 (no)	1998-06-12
DE69627880T2 (de)	2004-03-11

Publication	Publication Date	Title
PT1238659E (pt)	2005-01-31	Libertacao sustentada de um agente activo utilizando um sistema implantavel
PT868184E (pt)	2003-09-30	Microgranulos de libertacao prolongada contendo diltiazem como principio activo
DE69725373D1 (de)	2003-11-13	Aktives Implantat
PT1028961E (pt)	2005-01-31	Derivados de pleuromutilina como agentes antimicrobianos
PT888359E (pt)	2002-10-31	Derivados de pirimidin-4-ona como pesticida
LU90115B1 (fr)	1997-09-10	Formulation orale de 2-méthyl-thiéno-benzodiazépine
ID22878A (id)	1999-12-16	Komposisi aktif secara terapi
KR970006279A (ko)	1997-02-19	약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물
DE69819481D1 (de)	2003-12-11	Formulierungen von clarithromycin mit verlängerter wirkstoff-freisetzung
DE69612150D1 (de)	2001-04-26	Aktives Handsteuerknüppelsystem
DK0805625T3 (da)	2000-09-11	Insekticidt aktiv sammensætning
NO20005150L (no)	2000-12-08	Inkorporering av aktive substanser i bærermatriser
PT1066029E (pt)	2003-02-28	Suspensao de ingredientes activo peroral
PT1028718E (pt)	2003-07-31	Formulacao de libertacao prolongada
ZA988718B (en)	1999-04-01	Drug formulation having controlled release of active compound
NZ318391A (en)	1999-08-30	Fungicidal compositions comprising fenazaquine as an active substance
PT746979E (pt)	2004-10-29	Utilizacao de compostos pirrolo como agentes anti-incrustadores
ID29966A (id)	2001-10-25	Sulfoniloksazolamina-sulfoniloksazolamina sebagai senyawa-senyawa aktif terapi
ID24677A (id)	2000-07-27	Kombinasi senyawa aktif fungisidal
ATE241392T1 (de)	2003-06-15	Verbesserter absorbierender körper
PT928192E (pt)	2002-10-31	Gel antimicotico com elevada libertacao de principio activo
NO963871D0 (no)	1996-09-16	Kombinasjoner av aktive insektisidforbindelser
BR9609081A (pt)	1999-02-02	Combinações de substáncias ativas
PT906101E (pt)	2002-09-30	Formulacoes farmaceuticas de libertacao prolongada contendo mizolastina
ID23928A (id)	2000-05-25	Formulasi mengandung insektisida